Abstract
Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disease with variable presentation, course, and prognosis. Despite advances in diagnosis and treatment, it remains associated with significant morbidity and mortality. Early identification of patients at higher risk of negative outcomes may assist in closer monitoring and aggressive treatment, as well as in identifying…